Acta Chir Orthop Traumatol Cech. 2013; 80(3):219-225 | DOI: 10.55095/achot2013/035

Analýza krevních ztrát po primární TEP kyčle a kolenaPůvodní práce

J. Loą»ák1, J. Gallo1,*, D. Mlčůchová2,3
1 Ortopedická klinika FN a Univerzita Palackého v Olomouci
2 Univerzita Palackého v Olomouci, Přírodovědecká fakulta, Katedra matematické analýzy a aplikací matematiky
3 Univerzita Palackého v Olomouci, Přírodovědecká fakulta, Katedra geoinformatiky

PURPOSE OF THE STUDY:
The primary aim of the study was to identify characteristics predicting the blood loss associated with primary total hip (THA) and knee (TKA) arthroplasty surgery. The other objective was to find out which characteristics were important for peri-operative allogeneic blood transfusion in the same group of patients.

MATERIAL AND METHODS:
This prospective study comprised 210 consecutive patients who underwent primary THA (n = 115) or primary TKA (n = 95) at our department. In each patient, 21 pre-operative and peri-operative characteristics were recorded. Of them, the following characteristics were selected for statistical evaluation: age, gender, BMI, primary diagnosis, Charlson co-morbidity score, type of prophylaxis for deep-vein thrombosis, type of implant fixation (in THA), pre-operative INR value, haematocrit, haemoglobin (Hb) and platelet levels, amount of autologous blood donated by the patient, ASA score, operative time, use of tourniquet (in TKA), type of anaesthesia used, blood recuperation and patient's smoking habits. Multivariate analysis was used as the statistical method. For hypothesis testing, a statistical significance level of 0.05 was stated and, for enclosing (removing) characteristics to (from) multivariate models, the significance level was set at 0.11.

RESULTS:
The group included 81 men and 129 women; the mean age at the time of surgery was 65.5 ± 11.97 years (mean±SD) in the THA patients and 68.5 ± 8.52 years in the TKA patients. Primary osteoarthritis was the most frequent surgical diagnosis (THA, 64.35%; TKA, 82.1%). The mean amount of blood loss was 1258 ± 402.6 ml in THA and 1580 ± 475.5 ml in TKA. The mean amount of allogeneic blood required was 130 ± 202 ml when all THA patients were considered, and 371.95 ± 159.3 ml when only those who received it were involved. For the TKA patients, the corresponding values were 160.1 ± 278.8 ml for all patients and 507 ± 264.5 ml for blood recipients only. The characteristics that affected the amount of blood loss in THA included BMI, ASA score, blood recuperation, type of anaesthesia, and smoking habits; in TKA these were BMI, pre-operative platelet count, INR and type of anaesthesia. High pre-operative Hb levels made the probability of allogeneic blood requirement lower in both THA and TKA. Autotransfusion decreased the probability of allogeneic blood requirements only in THA.

DISCUSSION:
That the pre-operative Hb level is the strongest predictor for the probability of allogeneic blood transfusion during both THA and TKA is a logical and well-known fact. What remains to be established is the optimal protocol for pre-operative preparation of the patients with low Hb levels undergoing elective replacement (hip and knee) surgery. This study clearly showed that, in THA patients, pre-operative autologous blood donation decreased the probability of allogeneic blood transfusion. Other results of our multivariate analyses were not clinically unambiguous and therefore further research on a larger patient group is warranted. Such studies will also require the development of a more exact method for the assessment of blood loss at the operating theatre.

CONCLUSION:
The patients with low pre-operative Hb levels have a high probability that they will require allogeneic blood transfusion during primary THA and TKA. Autologous blood donation can decrease this probability significantly (here proved only for THA patients). The multivariate model of blood loss published here could assist in estimation of peri-operative blood loss and potential risk of blood transfusion requirements.

Klíčová slova: total hip arthroplasty, total knee arthroplasty, blood loss, allogeneic blood transfusion, pre-operative haemoglobin, autotransfusion, multivariate analysis

Zveřejněno: 1. červen 2013  Zobrazit citaci

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Loą»ák J, Gallo J, Mlčůchová D. Analýza krevních ztrát po primární TEP kyčle a kolena. Acta Chir Orthop Traumatol Cech. 2013;80(3):219-225. doi: 10.55095/achot2013/035. PubMed PMID: 23777948.
Stáhnout citaci

Reference

  1. ADERINTO, J., BRENKEL, I. J.: Pre-operative predictors of the requirement for blood transfusion following total hip replacement. J. Bone Jt Surg., 86-B: 970-973, 2004. Přejít k původnímu zdroji... Přejít na PubMed...
  2. BELL, T. H., BERTA, D., RALLEY, F., MACDONALD, S. J., MCCALDEN, R. W., BOURNE, R. B., RORABECK, C. H., NAUDIE, D. D.: Factors affecting perioperative bloodloss and transfusion rates in primary total joint arthroplasty: a prospective analysis of 1642 patients. Can. J. Surg., 52: 295-301, 2009.
  3. BEZWADA, H. P., NAZARIAN, D. G., HENRY, D. H., BOOTH, R. E., JR.: Preoperative use of recombinant human erythropoietin before total joint arthroplasty. J. Bone Jt Surg., 85-A: 1795-800, 2003. Přejít k původnímu zdroji... Přejít na PubMed...
  4. BIERBAUM, B. E., CALLAGHAN, J. J., GALANTE, J. O., RUBASH, H. E., TOOMS, R. E., WELCH, R. B.: Analysis of blood management in patient shaving a total hip or knee arthroplasty. J. Bone Jt Surg., 81-A: 2-10, 1999. Přejít k původnímu zdroji... Přejít na PubMed...
  5. BILLOTE, D. B., GLISSON, S. N., GREEN, D., WIXSON, R. L.: Efficacy of preoperative autologous blood donation: analysis of blood loss and transfusion practice in total hip replacement. J. Clin. Anesth., 12: 537-542, 2000. Přejít k původnímu zdroji... Přejít na PubMed...
  6. BONG, M. R., PATEL, V., CHANG, E., ISSACK, P. S., HEBERT, R., DI CESARE, P. E.: Risks associated with blood transfusion after total knee arthroplasty. J. Arthroplasty, 19: 281-287, 2004. Přejít k původnímu zdroji... Přejít na PubMed...
  7. BOWDITCH, M. G., VILLAR, R. N.: Do obese patients bleed more? A prospective study of blood loss at total hip replacement. Ann. R. Coll. Surg. Engl., 81: 198-200, 1999.
  8. CARSON, J. L., TERRIN, M. L., NOVECK, H., SANDERS, D. W., CHAITMAN, B. R., RHOADS, G. G., NEMO, G., DRAGERT, K., BEAUPRE, L., HILDEBRAND, K., MACAULAY, W., LEWIS, C., COOK, D. R., DOBBIN, G., ZAKRIYA, K. J., APPLE, F. S., HORNEY, R. A., MAGAZINER, J., FOCUS INVESTIGATORS: Liberal or restrictive transfusion in high-risk patients after hip surgery. N. Engl. J. Med., 365: 2453-2462, 2011. Přejít k původnímu zdroji... Přejít na PubMed...
  9. GROSFLAM, J. M., WRIGHT, E. A., CLEARY, P. D., KATZ, J. N.: Predictors of blood loss during total hip replacement surgery. Arthritis Care Res., 8: 167-173, 1995. Přejít k původnímu zdroji... Přejít na PubMed...
  10. HERSEKLI, M. A., AKPINAR, S., OZKOC, G., OZALAY, M., UYSAL, M., CESUR, N., TANDOGAN, R. N.: The timing of tourniquet release and its influence on blood loss after total knee arthroplasty. Int. Orthop., 28: 138-141, 2004. Přejít k původnímu zdroji... Přejít na PubMed...
  11. JANS, O., KEHLET, H., JOHANSSON, P. I.: Transfusion-related mortality after primary hip arthroplasty - analysis of mechanisms and confounders. Vox. Sang., 103: 301-308, 2012. Přejít k původnímu zdroji... Přejít na PubMed...
  12. JONES, H. W., SAVAGE, L., WHITE, C., GODDARD, R., LUMLEY, H., KASHIF, E., GURUSANY, K.: Postoperative autologous blood salvage drains - are they useful in primary uncemented hip and knee arthroplasty? A prospective study of 186 cases. Acta Orthop. Belg., 70: 466-473, 2004.
  13. KARKOUTI, K., MCCLUSKEY, S. A., EVANS, L., MAHOMED, N., GHANNAM, M., DAVEY, R.: Erythropoietin is an effective clinical modality for reducing RBC transfusion in joint surgery. Can. J. Anaesth., 52: 362-368, 2005. Přejít k původnímu zdroji... Přejít na PubMed...
  14. KOTZE, A., CARTER, L. A., SCALLY, A. J.: Effect of a patient blood management programme on preoperative anaemia, transfusion rate, and outcome after primary hip or knee arthroplasty: a quality improvement cycle. Br. J. Anaesth., 108: 943-952, 2012. Přejít k původnímu zdroji... Přejít na PubMed...
  15. KROHN, C. D., REIKERAS, O., BJORNSEN, S., BROSSTAD, F.: Fibrinolytic activity and postoperative salvaged untreated blood for autologous transfusion in major orthopaedic surgery. Eur. J. Surg., 167: 168-172, 2001. Přejít k původnímu zdroji... Přejít na PubMed...
  16. KUCERA, B., NAHLIK, D., HART, R., OCELAKOVA, L.: Post-operative retransfusion and intra-operative autotransfusion systems in total knee arthroplasty. A comparison of their efficacy. Acta Chir. orthop. Traum. čech., 79: 361-366, 2012. Přejít k původnímu zdroji...
  17. LAFFOSSE, J. M., CHIRON, P., MOLINIER, F., BENSAFI, H., PUGET, J.: Prospective and comparative study of the anterolateral mini-invasive approach versus minimally invasive posterior approach for primary total hip replacement. Early results. Int. Orthop., 31: 597-603, 2007. Přejít k původnímu zdroji... Přejít na PubMed...
  18. LAWRENCE, V. A., SILVERSTEIN, J. H., CORNELL, J. E., PEDERSON, T., NOVECK, H., CARSON, J. L.: Higher Hb level is associated with better early functional recovery after hip fracture repair. Transfusion, 43: 1717-1722, 2003. Přejít k původnímu zdroji... Přejít na PubMed...
  19. MARKAR, S. R., JONES, G. G., KARTHIKESALINGAM, A., SEGAREN, N., PATEL, R. V.: Transfusion drains versus suction drains in total knee replacement: meta-analysis. Knee Surg. SportsTraumatol. Arthrosc., 20: 1766-1772, 2012. Přejít k původnímu zdroji... Přejít na PubMed...
  20. NOTICEWALA, M. S., NYCE, J. D., WANG, W., GELLER, J. A., MACAULAY, W.: Predicting need for allogeneic transfusion after total knee arthroplasty. J. Arthroplasty, 27: 961-967, 2012. Přejít k původnímu zdroji... Přejít na PubMed...
  21. PARVIZI, J., CHAUDHRY, S., RASOULI, M. R., PULIDO, L., JOSHI, A., HERMAN, J. H., ROTHMAN, R. H.: Who needs autologous blood donation in joint replacement? J. Knee Surg., 24: 25-31, 2011. Přejít k původnímu zdroji... Přejít na PubMed...
  22. PRASAD, N., PADMANABHAN, V., MULLAJI, A.: Blood loss in total knee arthroplasty: analysis of risk factors. Int. Orthop., 31: 39-44, 2007. Přejít k původnímu zdroji... Přejít na PubMed...
  23. RASHIQ, S., FINEGAN, B. A.: The effect of spinal anesthesia on blood transfusion rate in total joint arthroplasty. Can. J. Surg., 49: 391-396, 2006.
  24. RICHMAN, J. M., ROWLINGSON, A. J., MAINE, D. N., COURPAS, G. E., WELLER, J. F., LU, C. L.: Does neuraxial anesthesia reduce intraoperative blood loss? A meta-analysis. J. Clin. Anesth., 18: 427-435, 2006. Přejít k původnímu zdroji... Přejít na PubMed...
  25. SALIDO, J. A., MARIN, L. A., GOMEZ, L. A., ZORRILLA, P., MARTINEZ, C.: Preoperative hemoglobin levels and the need for transfusion after prosthetic hip and knee surgery: analysis of predictive factors. J. Bone Jt Surg., 84-A: 216-220, 2002. Přejít k původnímu zdroji... Přejít na PubMed...
  26. SASANUMA, H., SEKIYA, H., TAKATOKU, K., TAKADA, H., SUGIMOTO, N., HOSHINO, Y.: Efficient strategy for controlling postoperative hemorrhage in total knee arthroplasty. Knee Surg. SportsTraumatol. Arthrosc., 19: 921-925, 2011. Přejít k původnímu zdroji... Přejít na PubMed...
  27. SCULCO, T. P., GALLINA, J.: Blood management experience: relationship between autologous blood donation and transfusion in orthopedic surgery. Orthopedics, 22(Suppl): s129, 1999. Přejít k původnímu zdroji... Přejít na PubMed...
  28. SEHAT, K. R., EVANS, R. L., NEWMAN, J. H.: Hidden blood loss following hip and knee arthroplasty. Correct management of blood loss should také hidden lossing to account. J. Bone Jt Surg., 86-B: 561-565, 2004. Přejít k původnímu zdroji...
  29. STEFFIN, B., GREEN-RIVIERE, E., GIORI, N. J.: Timing of tourniquet release in total knee arthroplasty when using a postoperative blood salvage drain. J. Arthroplasty, 24: 539-542, 2009. Přejít k původnímu zdroji... Přejít na PubMed...
  30. VARGAS-PABON, M., DIAZ-TRAPIELLA, A., HURTADO, M. J., DIAZ VARELA, N., CERRA SABIO, J. L.: Erythropoietin as adjuvant to pre-operative autologous blood donation in total hip arthroplasty: new algorithm for use. Transfus. Apher. Sci., 33: 91-97, 2005. Přejít k původnímu zdroji... Přejít na PubMed...
  31. WALSH, M., PRESTON, C., BONG, M., PATEL, V., DI CESARE, P. E.: Relative risk factors for requirement of blood transfusion after total hip arthroplasty. J. Arthroplasty, 22: 1162-1167, 2007. Přejít k původnímu zdroji... Přejít na PubMed...